DaVita Venture Group

DaVita Venture Group functions as the strategic investment and development arm of DaVita, identifying and co-developing innovative solutions. The group specifically targets products and businesses designed to improve care and quality of life for patients with kidney disease and chronic conditions. Its focus spans digital health, pharmaceuticals, medical devices, and advanced care delivery models for impactful improvements.

Launched by parent company DaVita on May 5, 2020, the Venture Group originated from the insight that ongoing innovation is vital. This initiative directs strategic and financial resources towards comprehensive solutions, advancing patient care beyond conventional dialysis and transforming kidney health across the full spectrum of needs.

The group primarily serves kidney disease patients by partnering with innovators developing targeted solutions. Its long-term vision is to redefine kidney health through expanded access to advanced treatments and improved clinical outcomes. They also accelerate value-based care models, aiming for more effective and cost-efficient solutions.